Deacetyl-7-xylosyltaxol C
CAS: 90332-65-3
Ref. 3D-QDA33265
| 1mg | A consultar | |
| 5mg | A consultar | |
| 10mg | A consultar | |
| 25mg | A consultar | |
| 50mg | A consultar |
Informação sobre produto
- 10-Deacetyl-7-xylosyltaxol C
- 10-Deacetylpaclitaxel C 7-xyloside
- 10-Deacetyltaxol C 7-xyloside
- 7,11-Methano-1H-cyclodeca[3,4]benz[1,2-b]oxete, benzenepropanoic acid deriv.
- 7-(b-Xylosyl)-10-deacetyltaxol C
- 7-Xylosyl-10-deacetyltaxol C
- Benzenepropanoic acid, α-hydroxy-β-[(1-oxohexyl)amino]-, (2aR,4S,4aS,6R,9S,11S,12S,12aR,12bS)-12b-(acetyloxy)-12-(benzoyloxy)-2a,3,4,4a,5,6,9,10,11,12,12a,12b-dodecahydro-6,11-dihydroxy-4a,8,13,13-tetramethyl-5-oxo-4-(β-<span class="text-smallcaps">D</span>-xylopyranosyloxy)-7,11-methano-1H-cyclodeca[3,4]benz[1,2-b]oxet-9-yl ester, (αR,βS)-
- Benzenepropanoic acid, α-hydroxy-β-[(1-oxohexyl)amino]-, 12b-(acetyloxy)-12-(benzoyloxy)-2a,3,4,4a,5,6,9,10,11,12,12a,12b-dodecahydro-6,11-dihydroxy-4a,8,13,13-tetramethyl-5-oxo-4-(β-<span class="text-smallcaps">D</span>-xylopyranosyloxy)-7,11-methano-1H-cyclodeca[3,4]benz[1,2-b]oxet-9-yl ester, [2aR-[2aα,4β,4aβ,6β,9α(αR*,βS*),11α,12α,12aα,12bα]]-
- Benzenepropanoicacid, a-hydroxy-b-[(1-oxohexyl)amino]-,12b-(acetyloxy)-12-(benzoyloxy)-2a,3,4,4a,5,6,9,10,11,12,12a,12b-dodecahydro-6,11-dihydroxy-4a,8,13,13-tetramethyl-5-oxo-4-(b-D-xylopyranosyloxy)-7,11-methano-1H-cyclodeca[3,4]benz[1,2-b]oxet-9-ylester, [2aR-[2aa,4b,4ab,6b,9a(aR*,bS*),11a,12a,12aa,12ba]]-
Deacetyl-7-xylosyltaxol C is a taxoid that is used in cancer treatment. It has been shown to be effective for the treatment of uncomplicated cancers, such as breast and prostate cancers, with a low risk of recurrence. Deacetyl-7-xylosyltaxol C binds to microtubules and prevents the production of tubulin, which leads to cell cycle arrest and apoptosis. The drug also inhibits the synthesis of DNA, RNA and proteins, which may lead to cell death. Deacetyl-7-xylosyltaxol C has been shown to be active against drug-resistant cells by inhibiting the production of topoisomerase II alpha (topo IIα) and reducing the binding affinity of paclitaxel to tubulin.
Propriedades químicas
Consulta técnica sobre: 3D-QDA33265 Deacetyl-7-xylosyltaxol C
Se desejar solicitar um orçamento ou fazer uma encomenda, por favor, adicione os produtos ao seu carrinho e depois solicite um orçamento ou encomenda a partir do carrinho. É mais rápido, mais barato e poderá beneficiar-se dos descontos e outras vantagens disponíveis.
